Companies

Akriveia Therapeutics

Description: Akriveia is developing a novel platform for next-generation protein therapeutics for cancer, with an initial focus on monoclonal antibodies in the immuno-oncology (I-O) area.

Location: Thousand Oaks, California

Sector: Healthcare

Year Invested: 2016

Status: Private

Websitewww.akriveiatx.com

Back to Companies

Associated Team Members